BIOLIFE SOLUTIONS INC (BLFS)

↓ Download CSV

CIK 0000834365 · Nasdaq · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, BIOLIFE SOLUTIONS INC reported revenue of $96.21M, up 28.9% from the prior year. The company ran a net loss, with a net margin of -4.8% and a gross margin of 64.6%. It held $405.88M in total assets against $34.00M in total liabilities.

Key ratios (FY2025)

64.6%
Gross margin
-17.3%
Operating margin
-4.8%
Net margin
-1.2%
Return on equity
+28.9%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$96.21M$74.65M$68.02M$76.24M$119.16M$48.09M$27.37M$19.74M$11.02M
Cost of Revenue$34.10M$24.55M$26.70M
Gross Profit$62.12M$50.10M$41.32M$13.53M$6.75M$4.78M
Operating Income-$16.60M-$4.48M-$17.20M-$5.92M-$35.16M-$6.24M-$220.0K$3.66M-$1.06M-$4.85M
Net Income-$4.59M-$20.18M-$68.00M-$139.81M-$8.91M$1.98M-$1.66M-$25.00M-$2.52M-$6.88M
EPS (Diluted)$-0.10$-0.44$-1.55$-3.25$-0.23$-0.06$-0.09$-1.56$-0.21
Total Assets$405.88M$399.49M$412.71M$450.23M$554.29M$234.83M$92.82M$45.47M$12.14M$7.93M
Total Liabilities$34.00M$50.58M$75.05M$86.04M$76.24M$29.58M$49.36M$30.84M$2.05M$4.76M
Shareholders' Equity$371.89M$348.91M$337.66M$364.19M$478.05M$204.43M$43.32M$14.63M-$9.53M$3.17M
Cash & Equivalents$33.04M$91.54M$27.90M$19.44M$69.86M$90.40M$6.45M$30.66M$6.66M$1.41M
Operating Cash Flow$20.11M$8.43M-$12.50M-$8.49M-$4.59M$6.64M$1.21M$2.35M$605.0K-$4.33M
Capital Expenditures$9.48M$3.23M$6.38M$10.38M$8.38M$1.96M$675.0K$500.0K$144.0K$143.5K
Shares Outstanding48.20M46.91M45.17M42.83M41.82M33.04M20.83M18.55M14.02M12.86M